Research on the drug, known as DYR533, was conducted at the the University of Arizona R. Ken Coit College of Pharmacy and BIO5 Institute, in partnership with the Biodesign Institute in Phoenix.
Queen Elizabeth II, sadly died on 8 September this year. Her Christian faith was the central plank on which her servant leadership was based. And yet her personal life, like so many of ours, has at times been filled with hurt and sadness.
Researchers have developed a new class of drugs that is able to cross the blood-brain barrier. The technology has been licensed to the startup Teleport Pharmaceuticals.